promoter drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| enhancer | interacts_with | promoter | 0.05 | 1 |
| RNA polymerase II | interacts_with | promoter | — | 1 |
Mentioned in (14)
Papers in which this entity is mentioned.
- Nanopore-based cell-free DNA fragmentation and methylation profiles from the cerebral spinal fluid of patients with lung cancer brain metastases. (2025)
- Sequence modeling and design from molecular to genome scale with Evo. (2024)
- Epigenome-wide change and variation in DNA methylation in childhood: trajectories from birth to late adolescence. (2021)
- Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. (2021)
- Highly Efficient CRISPR-Cas9-Based Methods for Generating Deletion Mutations and F0 Embryos that Lack Gene Function in Zebrafish. (2019)
- Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. (2018)
- Nanopore Sequencing Reveals High-Resolution Structural Variation in the Cancer Genome (2017)
- Genetic effects on gene expression across human tissues. (2017)
- Nuclear organization and 3D chromatin architecture in cognition and neuropsychiatric disorders. (2016)
- A comprehensive view of the epigenetic landscape part I: DNA methylation, passive and active DNA demethylation pathways and histone variants. (2015)
- An atlas of active enhancers across human cell types and tissues. (2014)
- Genetic variability in the regulation of gene expression in ten regions of the human brain. (2014)
- Landscape of transcription in human cells. (2012)
- Alcohol exposure alters DNA methylation profiles in mouse embryos at early neurulation. (2009)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| promoter | drug | 10 | 10 |
| promoter region | drug | 6 | 7 |